Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-03

Clinical Trial Update: Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) [NA]

View source ↗

Summary

Completed head-to-head clinical trial comparing initial dexamethasone intravitreal implant (Ozurdex) versus bevacizumab (Avastin) for macular edema due to centr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Long Island Vitreoretinal Consultants | Conditions: Macular Edema, Central Retinal Vein Occlusion | NA | Status: COMPLETED | Results posted: 2018-04-03